Key facts
- Praemostro’s last known valuation is $180K (Dec 2024).
- It has raised $100K; the latest was Accelerator/Incubator ($70K) in Jan 2026.
- Notable investors include InnoFounder, Science Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Praemostro
- ·The full record, as it builds
Funding rounds
No funding rounds for Praemostro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Praemostro
Developer of prediction software designed for forecasting patient attendance in emergency departments and other healthcare settings. The company's software uses artificial intelligence to predict the number of incoming patients, from a few hours to several months, enabling healthcare providers such as hospitals and emergency departments to optimize staffing, resources, and operations, improving efficiency, safety, and service quality while reducing overcrowding and operational costs.
- Sector
- Healthcare
- HQ
- Odense, Denmark
- Founded
- 2022
- Employees
- 1
- Website
- praemostro.com/
- Ownership
- Privately Held (backing)
Praemostro doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Praemostro shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Praemostro in its N-PORT filings yet. We sweep new filings monthly.